Back
Lixte Biotechnology Holdings Vs. Hims & Hers Health Industry Stock Comparison
Sell
32
LIXT
Lixte Biotechnology Holdings
Last Price:
2.21
Seasonality Move:
-4.66%
Buy
82
HIMS
Hims & Hers Health
Last Price:
30.67
Seasonality Move:
21.12%
Sell
32
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $2.07. The Score for LIXT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Hims & Hers Health (HIMS)
is a Buy
Is Hims & Hers Health a Buy, Sell or Hold?
- The current Hims & Hers Health [HIMS] share price is $31.35. The Score for HIMS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- HIMS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $2.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LIXT is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $31.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 62.31 | Buy |
| Chaikin Money Flow: | 63396 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.52 - 1.98) | Buy |
| Bollinger Bands (100): | (1.71 - 2.21) | Buy |
HIMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.46 | Buy |
| Relative Strength Index (14 RSI): | 66.48 | Buy |
| Chaikin Money Flow: | 48097363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.97 - 25.87) | Buy |
| Bollinger Bands (100): | (15.86 - 22.8) | Buy |
LIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.63 | Buy |
| 20-day SMA: | 1.77 | Buy |
| 50-day SMA: | 1.81 | Buy |
| 200-day SMA: | 2.32 | Sell |
| 8-day EMA: | 1.7 | Buy |
| 20-day EMA: | 1.72 | Buy |
| 50-day EMA: | 1.81 | Buy |
| 200-day EMA: | 2.31 | Sell |
HIMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.41 | Buy |
| 20-day SMA: | 23.09 | Buy |
| 50-day SMA: | 20.75 | Buy |
| 200-day SMA: | 17.47 | Buy |
| 8-day EMA: | 25.2 | Buy |
| 20-day EMA: | 23.55 | Buy |
| 50-day EMA: | 21.46 | Buy |
| 200-day EMA: | 17.43 | Buy |
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.13 per share.
Lixte Biotechnology Holdings Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hims & Hers Health Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||